ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC13520-1mg |
|
198694-74-5 |
MLCK inhibitor peptide
|
0 | C68H113N23O12 | |
GC13519-10mg |
|
1402837-78-8 |
Navoximod
|
0 | C18H21FN2O2 | |
GC13519-5mg |
|
1402837-78-8 |
Navoximod
|
0 | C18H21FN2O2 | |
GC13518-10mM (in 1mL DMSO) |
|
226256-56-0 |
Cinacalcet
|
0 | C22H22F3N | |
GC13518-500mg |
|
226256-56-0 |
Cinacalcet
|
0 | C22H22F3N | |
GC13518-50mg |
|
226256-56-0 |
Cinacalcet
|
0 | C22H22F3N | |
GC13517-10mM (in 1mL DMSO) |
|
126150-97-8 |
BAPTA-AM
|
0 | C34H40N2O18 | |
GC13517-50mg |
|
126150-97-8 |
BAPTA-AM
|
0 | C34H40N2O18 | |
GC13517-10mg |
|
126150-97-8 |
BAPTA-AM
|
0 | C34H40N2O18 | |
GC13516-10mM (in 1mL DMSO) |
|
1203680-76-5 |
AS 1949490
|
0 | C20H18ClNO2S | |
GC13516-5mg |
|
1203680-76-5 |
AS 1949490
|
0 | C20H18ClNO2S | |
GC13516-50mg |
|
1203680-76-5 |
AS 1949490
|
0 | C20H18ClNO2S | |
GC13516-10mg |
|
1203680-76-5 |
AS 1949490
|
0 | C20H18ClNO2S | |
GC13515-50mg |
|
23930-19-0 |
Alphaxalone
|
0 | C21H32O3 | |
GC13515-10mg |
|
23930-19-0 |
Alphaxalone
|
0 | C21H32O3 | |
GC13514-1g |
|
1315355-93-1 |
NG25
|
0 | C29H30F3N5O2 | |
GC13514-500mg |
|
1315355-93-1 |
NG25
|
0 | C29H30F3N5O2 | |
GC13514-10mg |
|
1315355-93-1 |
NG25
|
0 | C29H30F3N5O2 | |
GC13514-5mg |
|
1315355-93-1 |
NG25
|
0 | C29H30F3N5O2 | |
GC13513-25mg |
|
317321-41-8 |
O-1602
|
0 | C17H22O2 | |